Hikma Pharmaceutical | HIK - Market Capitalization

Stock Price
1,632.00
Daily Change
78.00 5.02%
Monthly
6.88%
Yearly
-28.48%
Q1 Forecast
1,498.57

Hikma Pharmaceutical reported $3.55B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Almirall EUR 2.29B 527.4M Jun/2025
argenx SE USD 44.32B 15.63B Sep/2025
AstraZeneca USD 233.07B 17.56B Sep/2025
Autolus Therapeutics Ltd USD 433.81M 172.99M Sep/2025
Bayer EUR 27.23B 2.14B Sep/2025
Fresenius EUR 26.7B 2.66B Sep/2025
Galapagos EUR 1.92B 355.84M Sep/2025
Genmab DKK 80.88B 7.82B Jun/2025
GlaxoSmithKline GBP 86.59B 22.54B Feb/2026
GRIFOLS EUR 7.49B 1.16B Sep/2025
Hikma Pharmaceutical USD 6.06B 1.64B Jun/2025
Lonza CHF 39.68B 980.61M Jun/2025
Merck EUR 47.59B 239.13M Sep/2025
Orion EUR 9.18B 190.08M Sep/2025
Recordati EUR 10.81B 168.23M Sep/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
UCB EUR 32.47B 4.91B Jun/2025